A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus

Inclusion Criteria: * Patient has diagnosis of Diabetes Mellitus, Type I or II. * Patient has experienced the development of macular edema following cataract surgery in at least one eye. * Patient has had cataract surgery within 90 days prior to the screening visit. Exclusion Criteria: * Patient has other significant ocular disease in study eye, including glaucoma. * Patient has any active infection in the study eye. * Patient has uncontrolled systemic illness (i.e., uncontrolled blood pressure, uncontrolled diabetes mellitus). * Patient has experienced a significant increase in intraocular pressure following a prior treatment with topical or intravitreal steroidal medication. * Patient has received the OZURDEX® implant before in the study eye.